# Iconovo expands deal with Amneal for generic Symbicort, launches pharma division

Iconovo amended its development deal with Amneal for a generic version of Symbicort to add US and Chinese marketing rights for Amneal and Nordic region marketing rights for Iconovo, more than doubling potential future royalty income. Iconovo also launched a new pharma division, Iconovo Pharma.

- Type: Contract
- Announced: 2021-05-01
- Status: announced
- Products: generic Symbicort dry powder inhaler
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Iconovo](https://endata.com/companies/54817.md)
- [Amneal Pharmaceuticals](https://endata.com/companies/54818.md) (partner)

## Sources

- [oindpnews.com](https://www.oindpnews.com/2021/05/iconovo-announces-expansion-of-deal-with-amneal-on-generic-symbicort-and-launch-of-pharma-division/), 2021-05-01: "We are very pleased to have been able to expand our agreement with Amneal."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.